Considerations for the Development and Practice of Cascade Impaction Testing, Including a Mass Balance Failure Investigation Tree-Reference-Cited by-同舟云学术

Considerations for the Development and Practice of Cascade Impaction Testing, Including a Mass Balance Failure Investigation Tree

Published:2003-09 Issue:3 Volume:16 Page:235-247
ISSN:0894-2684
Container-title:Journal of Aerosol Medicine
language:en
Short-container-title:Journal of Aerosol Medicine

Author:

Christopher Dave¹,Curry Paul²,Doub Bill³,Furnkranz Kenneth⁴,Lavery Martin⁵,Lin Karl⁴,Lyapustina Svetlana⁶,Mitchell Jolyon⁷,Rogers Brian⁴,Strickland Helen⁸,Tougas Terrence²,Tsong Yi⁴,Wyka Bruce¹

Affiliation:

1. Schering-Plough Research Institute, Kenilworth, NJ

2. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT

3. U.S. FDA, St. Louis, MO

4. U.S. FDA, Rockville, MD

5. Aventis, Pharma Ltd., Holmes Chapel, UK

6. Gardner, Carton and Douglas, Washington, DC

7. Trudell Medical International, London, Ontario, Canada

8. GlaxoSmithKline, Inc., Research Triangle Park, NC

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pulmonary and Respiratory Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/089426803769017604

Reference11 articles.

1. Distortion of cascade impactor measured size distribution due to bounce and blow-off

2. Nonideal collection characteristics of single stage and cascade impactors

3. Measurement of Particle Size Characteristics of Metered Dose Inhaler (MDI) Aerosols

4. The Effect of Dose on the Characterization of Aerodynamic Particle-size Distributions of Beclomethasone Dipropionate Metered-dose Inhalers

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Using Dry Dispersion Laser Diffraction to Assess Dispersibility in Spheronized Agglomerate Formulations;AAPS PharmSciTech;2024-02-23

2. Addressing the Need for Controls on Particle Bounce and Re-entrainment in the Cascade Impactor and for the Mitigation of Electrostatic Charge for Aerodynamic Particle Size Assessment of Orally Inhaled Products: an Assessment by the International Consortium on Regulation and Science (IPAC-RS);AAPS PharmSciTech;2020-08-21

3. Nanomaterial-based blood-brain-barrier (BBB) crossing strategies;Biomaterials;2019-12

4. Dry-Powder Inhaler Formulation of Rifampicin: An Improved Targeted Delivery System for Alveolar Tuberculosis;Journal of Aerosol Medicine and Pulmonary Drug Delivery;2017-12

5. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol;AAPS PharmSciTech;2017-06-06